Reflections on a 10-Year Journey in the Microbiome
Following a fortuitous path, researcher Aaron Cowley established expertise in process development for live biotherapeutic products at his company Captozyme. Today, as... Read More
Arranta Bio Announces Key Leadership Additions As It Commits to a $100M Investment in Building End-to-End Microbiome Capacity
Arranta Bio, the leading microbiome contract development and manufacturing organization (CDMO), announced the strengthening of its senior leadership team with the addition... Read More
Oxidien Pharmaceuticals to Present at Biotech Showcase™ 2020 in San Francisco
UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an unmet kidney... Read More
Oxidien Pharmaceuticals Announces Favorable Response from FDA on Proposed Development Plan
UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for secondary hyperoxaluria, announced... Read More
